Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ Disease. SciELO Preprints, 2025. DOI: 10.1590/SciELOPreprints.12615. Disponível em: https://preprints.scielo.org/index.php/scielo/preprint/view/12615. Acesso em: 14 maio. 2026.